Home › Studies › PRJNA909041
PRJNA909041 SRP411529

GutAlive vs Zymo Shield stool kit, Asturias, Spain

GutAlive(R) enables DNA-based microbiome analysis without disrupting the original composition and diversity

32 fecal samples from 5 healthy adult donors in Asturias, Spain, comparing GutAlive and Zymo DNA/RNA Shield collection devices across four processing time points using shotgun metagenomics. machine-written summary

32 samples · 32 runs · ES · Age unknown · 2023 · 4.08 Gbp / sample

Sources
✓Sequence archive 224○Abstract / description✓Full text 128○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive224 sample values (collection date, country, latitude, location region, longitude, subject id, timepoint)
○ Abstract / descriptionread; no usable statement
✓ Full text128 sample values (antibiotic exposure, health condition, health condition detail, location site) · PMC10117842
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
adult32
Condition
healthy_control32
Country
ES32
Body site
primary32
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 2 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 30 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 4.08 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

4 of 5 people sampled more than once (31 samples; median 8, up to 8 per person).

How longitudinal and relatedness information is derived

Community composition
Bacteroides 5.6%Prevotella 4.5%Phocaeicola 4.3%Ruminococcoides 4.1%Blautia_A 4.0%Gemmiger 3.9%Faecalibacterium 3.9%Succinivibrio 3.3%Roseburia 2.5%Bifidobacterium 2.4%Alistipes 2.2%Vescimonas 1.9%not assigned to a genus 6.1%other genera 51.2%

Genera, mean relative abundance over 32 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category32 100%
country32 100%32
health_condition32 100%32
subject_id32 100%32
antibiotic_exposure32 100%32
collection_date32 100%32
detailed_location32 100%
health_condition_detail32 100%32
latitude32 100%32
location_region32 100%32
location_site32 100%32
longitude32 100%32
timepoint_label32 100%32
Papers (1)
  • GutAlive® enables DNA-based microbiome analysis without disrupting the original composition and diversity. 2023 PMID 37089545 PMC10117842 own_data
Details
Archive description

GutAlive enables microbiome analysis overtime

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.65. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • body site run.scientific_name · “human gut metagenome”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN32064825antibiotic_exposurenoR30.70paper.fulltext.methodsantibiotics or glucocorticoids in the previous 3 months
SAMN32064825collection_date2022R10.90biosample.attribute:collection_date2022
SAMN32064825countryESR10.90sample.attr.geo_loc_nameSpain: Asturias
SAMN32064825health_conditionhealthy_controlR30.70paper.fulltext.methodsfecal samples from four healthy donors
SAMN32064825health_condition_detailhealthy donorsR30.70paper.fulltext.methodsfecal samples from four healthy donors
SAMN32064825latitude43.3546R10.90biosample.attribute:lat_lon43.35462849 N 5.87166109 W
SAMN32064825location_regionAsturiasR10.85biosample.attribute:geo_loc_nameSpain: Asturias
SAMN32064825location_siteMicroviable Therapeutics SLR30.70paper.fulltext.methodscarried out at Microviable Therapeutics SL (Asturias, Spain)
SAMN32064825longitude-5.8717R10.90biosample.attribute:lat_lon43.35462849 N 5.87166109 W
SAMN32064825subject_id1R10.50sample.attr.donor1
SAMN32064825timepoint_label24R10.85biosample.attribute:time_hourstime_hours: 24
Sequencing

32 runs over 32 samples · mean 4.26 Gbp per run (median 4.08 Gbp, total 136.41 Gbp; 32 runs with a base count) · layout PAIRED 32 · platform ILLUMINA 32 · models Illumina NovaSeq 6000 (32) · 100% of runs with a Sandpiper profile · first public 2023-10-28

Authors (4)

Montero I first · Barrientos D · Hidalgo-Cantabrana C · Martínez-Álvarez N last

Downloads

PRJNA909041.csv.gz (1.7 KB) · parquet (71.5 KB) — all 32 samples, every field with route and confidence · PRJNA909041_determinations.csv.gz (2.9 KB) — 352 evidence rows

Samples (32 · every field this project has values for · hover a cell for its source)
Loading the sample table…